These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39350784)

  • 1. B-cell-specific signatures reveal novel immunophenotyping and therapeutic targets for hepatocellular carcinoma.
    Xu KQ; Gong Z; Yang JL; Xia CQ; Zhao JY; Chen X
    World J Gastroenterol; 2024 Sep; 30(34):3894-3925. PubMed ID: 39350784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High ratio of resident to exhausted CD4 + T cells predicts favorable prognosis and potentially better immunotherapeutic efficacy in hepatocellular carcinoma.
    Zuo A; Lv J; Jia W; Ba Y; Liu S; Zhang Y; Weng S; Xu H; Liu L; Wang L; Han X; Liu Z
    BMC Cancer; 2024 Sep; 24(1):1152. PubMed ID: 39289669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine-related genes participate in the establishment of an immunosuppressive microenvironment and impact the immunotherapy response in hepatocellular carcinoma.
    Zhang X; Zheng P; Meng B; Zhuang H; Lu B; Yao J; Han F; Luo S
    Clin Exp Med; 2024 Jun; 24(1):129. PubMed ID: 38884870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment.
    Wei S; Tan J; Huang X; Zhuang K; Qiu W; Chen M; Ye X; Wu M
    J Transl Med; 2024 Jul; 22(1):711. PubMed ID: 39085893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma.
    Wu Q; Li P; Tao X; Lin N; Mao B; Xie X
    BMC Cancer; 2024 Sep; 24(1):1087. PubMed ID: 39223584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic catastrophe heterogeneity: implications for prognosis and immunotherapy in hepatocellular carcinoma.
    Mao Z; Gao Z; Long R; Guo H; Chen L; Huan S; Yin G
    Front Immunol; 2024; 15():1409448. PubMed ID: 39015573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic model for predicting patient survival and immunotherapy responsiveness in hepatocellular carcinoma: insights into the involvement of T-cell proliferation.
    Tang S; Sun R; Tang K; Wei X; Liu M; Zhang H
    Clin Transl Oncol; 2024 Jun; 26(6):1368-1383. PubMed ID: 38123874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
    Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
    Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the interplay between bisphenol A exposure, the immune microenvironment and hepatocellular carcinoma progression.
    Liu Q; Niu R; Ye Y; Li J
    J Gene Med; 2024 Sep; 26(9):e3723. PubMed ID: 39228142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2024 Jun; 62(3):2332-2351. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive scRNA-seq Analysis and Identification of CD8_+T Cell Related Gene Markers for Predicting Prognosis and Drug Resistance of Hepatocellular Carcinoma.
    Cao L; Liu M; Ma X; Rong P; Zhang J; Wang W
    Curr Med Chem; 2024; 31(17):2414-2430. PubMed ID: 37936457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.